HK1057499A1 - Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity - Google Patents

Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Info

Publication number
HK1057499A1
HK1057499A1 HK04100307.4A HK04100307A HK1057499A1 HK 1057499 A1 HK1057499 A1 HK 1057499A1 HK 04100307 A HK04100307 A HK 04100307A HK 1057499 A1 HK1057499 A1 HK 1057499A1
Authority
HK
Hong Kong
Prior art keywords
prophylaxis
obesity
treatment
locating
compounds
Prior art date
Application number
HK04100307.4A
Inventor
Johannes Hebebrand
Jochen Antel
Ulf Preuschoff
Samuel David
Holger Sann
Michael Weske
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of HK1057499A1 publication Critical patent/HK1057499A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
HK04100307.4A 2000-07-20 2004-01-15 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity HK1057499A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035227A DE10035227A1 (en) 2000-07-20 2000-07-20 Selection and use of lipogenesis inhibitors for the treatment and prevention of obesity
PCT/EP2001/008051 WO2002007821A1 (en) 2000-07-20 2001-07-12 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Publications (1)

Publication Number Publication Date
HK1057499A1 true HK1057499A1 (en) 2004-04-08

Family

ID=7649538

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100307.4A HK1057499A1 (en) 2000-07-20 2004-01-15 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Country Status (27)

Country Link
EP (1) EP1307262B1 (en)
JP (1) JP2004504053A (en)
KR (1) KR100818827B1 (en)
CN (1) CN1443085B (en)
AR (1) AR028730A1 (en)
AT (1) ATE278441T1 (en)
AU (2) AU7753401A (en)
BR (1) BR0112547A (en)
CA (1) CA2416647A1 (en)
CZ (1) CZ2003156A3 (en)
DE (2) DE10035227A1 (en)
DZ (1) DZ3393A1 (en)
ES (1) ES2230346T3 (en)
HK (1) HK1057499A1 (en)
HU (1) HUP0302309A3 (en)
IL (2) IL153971A0 (en)
MX (1) MXPA02012907A (en)
NO (1) NO20030233L (en)
NZ (1) NZ523960A (en)
PL (1) PL201165B1 (en)
PT (1) PT1307262E (en)
RU (1) RU2268721C2 (en)
SK (1) SK287607B6 (en)
TR (1) TR200402670T4 (en)
TW (1) TWI274157B (en)
UA (1) UA74588C2 (en)
WO (1) WO2002007821A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1750712A2 (en) 2004-05-19 2007-02-14 Solvay Pharmaceuticals GmbH Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CA2609185A1 (en) 2005-05-20 2006-11-30 Ahmed F. Abdel-Magid Process for preparation of sulfamide derivatives
AR057570A1 (en) 2005-11-14 2007-12-05 Solvay Pharm Gmbh DERIVATIVES OF N-SULFAMOIL-N'-BENZOPIRANOPIPERIDINAS ESPIROCONDENSADAS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, A PROCEDURE FOR THEIR PREPARATION AND ITS USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY ISOIDAS IIB
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
AR058389A1 (en) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv USE OF SULFAMIDE BENZO-FUSED HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF OBESITY
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
EA200870556A1 (en) 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. COMBINED THERAPY IN THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
PL2106260T3 (en) 2007-01-25 2018-06-29 NAIA Metabolic, Inc. Insulin sensitisers and methods of treatment
AU2009271362B2 (en) 2008-06-23 2014-03-13 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
CN104487073A (en) * 2012-05-24 2015-04-01 维尔瓦制药有限公司 A method of improving liver function
CN106770611B (en) * 2016-12-22 2019-01-29 广西师范大学 A method of entering mitochondria for cell in-situ detection small molecule compound
RU2771430C1 (en) * 2021-09-21 2022-05-04 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Method for the quantitative determination of anticonvulsants in the blood plasma of patients with epilepsy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
DE69305091T2 (en) * 1992-10-29 1997-03-13 Genentech Inc METHOD FOR TREATING OR PREVENTING OBESITY
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
AU732923B2 (en) * 1996-06-28 2001-05-03 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant sulfamate derivatives useful in treating obesity
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor

Also Published As

Publication number Publication date
DE50104023D1 (en) 2004-11-11
TR200402670T4 (en) 2004-11-22
ATE278441T1 (en) 2004-10-15
RU2268721C2 (en) 2006-01-27
NO20030233L (en) 2003-03-19
WO2002007821A1 (en) 2002-01-31
KR20030022284A (en) 2003-03-15
IL153971A0 (en) 2003-07-31
TWI274157B (en) 2007-02-21
PL363518A1 (en) 2004-11-29
CZ2003156A3 (en) 2003-06-18
EP1307262B1 (en) 2004-10-06
AU2001277534B2 (en) 2005-09-29
DZ3393A1 (en) 2002-01-31
AR028730A1 (en) 2003-05-21
EP1307262A1 (en) 2003-05-07
AU2001277534B9 (en) 2006-02-23
KR100818827B1 (en) 2008-04-01
UA74588C2 (en) 2006-01-16
PL201165B1 (en) 2009-03-31
CN1443085A (en) 2003-09-17
AU7753401A (en) 2002-02-05
HUP0302309A2 (en) 2003-11-28
MXPA02012907A (en) 2003-09-22
CA2416647A1 (en) 2003-01-20
DE10035227A1 (en) 2002-01-31
PT1307262E (en) 2004-12-31
IL153971A (en) 2009-07-20
NO20030233D0 (en) 2003-01-17
ES2230346T3 (en) 2005-05-01
HUP0302309A3 (en) 2005-06-28
SK287607B6 (en) 2011-03-04
NZ523960A (en) 2004-12-24
BR0112547A (en) 2003-07-01
JP2004504053A (en) 2004-02-12
CN1443085B (en) 2010-04-28
SK612003A3 (en) 2003-06-03

Similar Documents

Publication Publication Date Title
PL364995A1 (en) Method for the treatment or prevention of flavivirus
HK1062518A1 (en) Materials and methods for the treatment or prevention of obesity
PL369237A1 (en) Micro-organisms for the treatment of soil and process for obtaining them
GB0014969D0 (en) Novel method of treatment
EP1416961A4 (en) Composition and method for the treatment of disease
IL153971A0 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
AU2001277534A1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
EP1337255A4 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
EP1442062A4 (en) Methods for the treatment of carcinoma
AU2003263760A1 (en) Methods for the treatment or prevention of obesity
HUP0302739A3 (en) Method for the treatment of tobacco
AU2002364171A8 (en) Materials and methods for the treatment or prevention of obesity
EP1359885A4 (en) Nos inhibitors for treatment of wrinkles
AU7750100A (en) Method for the treatment of obesity
EP1389105A4 (en) Method of treatment
AU6137801A (en) Method and composition for the treatment of angiogenesis
GB0112216D0 (en) Method of treatment
GB0008921D0 (en) Method of treatment
GB0118892D0 (en) Method of treatment
SI1307262T1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
GB0027001D0 (en) Method and apparatus for the treatment of sludge
IL161630A0 (en) Methods of treating endometreosis
GB0001861D0 (en) Method for the treatment of obesity
AU2000272704A1 (en) Use of compounds for the treatment of obesity
GB0106711D0 (en) Method and apparatus for treatment of conduits and the like

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140712